Dermatology

    Overview

    Dermatology is the branch of medicine dealing with the hair, nails, skin and the treatment of diseases affecting them.

    Our doctors

    Profiles

    Adam Berry, MD

    Dermatologist Dermatology, Internal Medicine
    Profiles

    Brittany Blaise, MD

    Dermatologist Dermatology
    751 N. Rutledge St. Suite 2300 Springfield, IL 62702
    Profiles

    Lucinda Buescher, MD

    Dermatologist Dermatology
    751 N. Rutledge St. Suite 2300 Springfield, IL 62702
    Profiles

    Joseph Conlon, MD

    Dermatologist Dermatology
    751 N. Rutledge St. Suite 2300 Springfield, IL 62702
    Profiles

    Rebecca Larson, MD

    Dermatologist Dermatology
    751 N. Rutledge St. Suite 2300 Springfield, IL 62702
    Profiles

    Elizabeth Nietert, MD

    Dermatologist Dermatology
    ,
    Profiles

    Morgan Wilson, MD

    Dermatologist Dermatology
    751 N. Rutledge St. Suite 2300 Springfield, IL 62702

    Why SIU

    Continually learning

    With a focus on continual improvement, our doctors take the time to research, study and innovate to provide the latest treatments for our patients.

    Patient-first experience

    Our care ranges from primary care physicians to specialists and sub-specialists who have advanced training. We're here for you when you need us.

    Breakthrough technology

    Continually teaching the next generation of doctors, our physicians use the latest developments in procedures and technologies for our patients.

    Our Locations

    Locations

    SIU Dermatology Clinic

    751 N. Rutledge St. Springfield, IL 62702
    Mon - Fri: 8:00 am-4:30 pm
    Locations

    SIU Pulmonology in Decatur

    102 W. Kenwood Ave. Decatur, IL 62526
    Mon - Fri: 8:00 am-4:30 pm

    Clinical trials

    Trial
    Dermatology

    Corrona Psoriasis (PSO) Registry

    Active recruiting

    The objective of the Corrona Psoriasis Registry is to create a national database of patients with psoriasis. Data collected will be used to study the  disease and to evaluate the effectiveness and safety of medications approved for the treatment of psoriasis.

    Trial
    Dermatology

    A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

    Active not recruiting

    The purpose of this study is to evaluate the long-term safety, tolerability, and effectiveness of PF-06651600(Ritlecitinib) in adult and adolescent (12 years and older) participants with Alopecia Areata.